Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Name: Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

high grade b-cell lymphoma with myc and bcl6 rearrangements, recurrent diffuse large b-cell lymphoma, recurrent diffuse large b-cell lymphoma germinal center b-cell type, recurrent diffuse large b-cell lymphoma, not otherwise specified, recurrent high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements, recurrent high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 249606
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.